Candel Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 8.65 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 661.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
Details
| Name | Candel Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 55 |
| Founded | 1999 |
| Ipo Date | 2021-07-27 |
| Ceo | Paul-Peter Tak |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 8.00 |
| Isin | US1374041093 |
| Cusip | 137404109 |
| Cik | 1841387 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. | President, Chief Executive Officer and Director |
| Charles Schoch | Senior Vice President, Chief Financial Officer, Treasurer and Secretary |
| Dr. Francesca Barone M.D., Ph.D. | Chief Scientific Officer |
| Dr. Seshu Tyagarajan Ph.D. | Chief Technical and Development Officer |
| Theodore Jenkins | Vice President of Investor Relations and Business Development |
| Ileen B. Winick | Chief People Officer |
| Susan Stewart J.D., L.L.M. | Chief Regulatory Officer |
| Dr. William Nichols Garrett M.D., M.S. | Chief Medical Officer |
| Mark Sims | Chief Commercial Officer |
Contact
| Address | 117 Kendrick Street, Suite 450, Needham, Massachusetts 02494, United States |
| Phone | 617 916 5445 |
| Website | https://www.candeltx.com |